CERo Therapeutics Holdings, Inc. (CERO) Financials
CERO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.9 million | 32.4 million |
| March 31, 2026 | 2.2 million | 11.5 million |
| Dec. 31, 2025 | 3.6 million | 9.1 million |
| Sept. 30, 2025 | 3.9 million | 8.5 million |
CERO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.3 million | 1.1 million |
| March 31, 2026 | -2.8 million | 1.6 million |
| Dec. 31, 2025 | -3.8 million | 1.1 million |
| Sept. 30, 2025 | -3.2 million | -515434 |
CERO Net Income
No data available :(
CERO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 937512 | - | 218308 |
| March 31, 2026 | 857489 | 136765 | 461580 |
| Dec. 31, 2025 | 1.7 million | - | 699107 |
| Sept. 30, 2025 | 2.0 million | - | 931023 |
CERO Shares Outstanding
CERO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 1.7 million | 2.1 million | - |
| March 31, 2026 | 3 | 2.3 million | 2.5 million | - |
| Dec. 31, 2025 | 3 | 2.3 million | 1.2 million | - |
| Sept. 30, 2025 | 5 | 2.4 million | 2.0 million | - |
CERO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 278691 |
| March 31, 2026 | - | 276142 |
| Dec. 31, 2025 | - | 276136 |
| Sept. 30, 2025 | - | 272766 |
CERO
Price: $0.01
52 week price:
Earnings Per Share: 84.10 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 496236